openPR Logo
Press release

Neuropathic Pain Therapeutics Market Outlook 2030: Projected to Reach US$ 10.2 Billion by 2030, Driven by Rising Prevalence and Therapeutic Advancements

07-03-2025 12:46 PM CET | Health & Medicine

Press release from: Transparency Market Research

Neuropathic Pain Therapeutics Market

Neuropathic Pain Therapeutics Market

The global Neuropathic Pain Therapeutics Market is projected to reach US$ 10.2 billion by 2030, expanding at a moderate compound annual growth rate (CAGR) of approximately 5% from 2020 to 2030. Neuropathic pain, caused by nerve damage from conditions like diabetes, chemotherapy, or injuries, is treated with medications such as anticonvulsants, antidepressants, and opioids. The market's growth is driven by rising prevalence of neuropathic pain, increasing chronic disease incidence, and advancements in pain management therapies. However, challenges such as side effects, regulatory complexities, and limited access in developing regions persist. This report provides a comprehensive analysis of the market, covering its overview, key drivers, challenges, regional insights, and future opportunities.

Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77666

Market Overview

The Neuropathic Pain Therapeutics Market includes pharmaceuticals like gabapentin, pregabalin, duloxetine, and emerging non-opioid therapies for conditions such as diabetic neuropathy and postherpetic neuralgia. The market is expected to reach US$ 10.2 billion by 2030, driven by a CAGR of ~5%. It is segmented by drug class (anticonvulsants, antidepressants, opioids, others), indication (diabetic neuropathy, postherpetic neuralgia, chemotherapy-induced neuropathy, others), distribution channel (hospital pharmacies, retail pharmacies, online), end-user (hospitals, clinics, homecare), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Anticonvulsants dominate due to their efficacy, while hospitals lead as end-users.

Key Drivers of Growth

Several factors are propelling the growth of the Neuropathic Pain Therapeutics Market:

Rising Prevalence of Neuropathic Pain: Increasing cases, affecting 7-10% of the global population, drive demand for effective pain management therapies.

Growing Chronic Disease Incidence: Rising diabetes (over 500 million cases globally) and cancer rates increase neuropathic pain cases, boosting market growth.

Advancements in Therapeutics: Innovations in non-opioid drugs, topical treatments, and neuromodulation therapies enhance efficacy and reduce side effects.

Aging Population: The global elderly population, projected to reach 1.4 billion by 2030, increases neuropathic pain incidence, supporting market expansion.

Supportive Regulatory Approvals: Fast-track designations for novel pain therapies by agencies like the FDA and EMA facilitate market entry.

Top Companies:

Pfizer
Novartis AG
AstraZeneca
GlaxoSmithKline
Eli Lilly and Company
Mallinckrodt Pharmaceuticals
Johnson & Johnson
Abbott
Endo Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Limited
Merck & Co., Inc.

Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/neuropathic-pain-therapeutics-market.html

Challenges and Barriers

Despite its growth potential, the market faces several challenges:

Side Effects of Therapies: Adverse effects like dizziness, dependency (opioids), or gastrointestinal issues reduce patient compliance.

Regulatory Complexities: Stringent regulations for controlled substances, particularly opioids, increase development costs and delay approvals.

Limited Access in Developing Regions: Inadequate healthcare infrastructure in Africa and parts of Asia-Pacific restricts market penetration.

High Treatment Costs: Advanced therapies and long-term treatment regimens are expensive, limiting affordability in low-income regions.

Competition from Alternatives: Non-pharmacological treatments like physical therapy and neuromodulation devices may reduce reliance on drugs.

Regional Insights

The Neuropathic Pain Therapeutics Market exhibits distinct regional dynamics:

North America: North America dominates, driven by high neuropathic pain prevalence, advanced healthcare systems, and robust R&D. The U.S. leads due to widespread drug availability.

Europe: Europe is a key market, with Germany, France, and the UK benefiting from strong healthcare policies and increasing diabetes rates.

Asia-Pacific: Asia-Pacific is expected to witness rapid growth, fueled by rising chronic disease prevalence, improving healthcare access, and investments in China, India, and Japan.

Latin America: Latin America shows moderate growth, with Brazil and Mexico leading due to expanding healthcare infrastructure. Limited awareness slows progress.

Middle East & Africa: This region has the smallest share due to limited healthcare access. Growth opportunities exist in Gulf countries with rising investments.

Future Opportunities

The Neuropathic Pain Therapeutics Market offers several avenues for growth and innovation:

Non-Opioid Therapies: Developing novel non-opioid drugs and biologics could address safety concerns and drive market demand.

Expansion in Emerging Markets: Increasing healthcare investments in Asia-Pacific and Latin America present opportunities for affordable treatment solutions.

Personalized Medicine: Tailoring therapies to patient-specific pain profiles could improve efficacy and market growth.

Digital Health Integration: Telemedicine and AI-driven pain management tools could enhance patient monitoring and adherence.

Partnerships with Pharma Companies: Collaborations can accelerate development and distribution of innovative neuropathic pain therapies.

Browse More Trending Research Reports:

Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html

Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html

Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html

Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neuropathic Pain Therapeutics Market Outlook 2030: Projected to Reach US$ 10.2 Billion by 2030, Driven by Rising Prevalence and Therapeutic Advancements here

News-ID: 4091130 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Neuropathic

Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others. The Neuropathic Ocular Pain market
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022 Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End. Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025. Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,